These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26552980)

  • 1. Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection.
    Lazzarini C; Esposto MC; Prigitano A; Cogliati M; De Lorenzis G; Tortorano AM
    Antimicrob Agents Chemother; 2016 Jan; 60(1):682-5. PubMed ID: 26552980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
    Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
    Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
    J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
    Arendrup MC; Jensen RH; Cuenca-Estrella M
    Antimicrob Agents Chemother; 2016 Jan; 60(1):532-6. PubMed ID: 26552973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in
    Rivero-Menendez O; Soto-Debran JC; Medina N; Lucio J; Mellado E; Alastruey-Izquierdo A
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, mechanisms and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan.
    Wang HC; Huang JC; Lin YH; Chen YH; Hsieh MI; Choi PC; Lo HJ; Liu WL; Hsu CS; Shih HI; Wu CJ; Chen YC
    Environ Microbiol; 2018 Jan; 20(1):270-280. PubMed ID: 29124846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC
    J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azole resistance in Aspergillus isolates by different types of patients and correlation with environment - An Italian prospective multicentre study (ARiA study).
    Prigitano A; Esposto MC; Grancini A; Biffi A; Innocenti P; Cavanna C; Lallitto F; Mollaschi EMG; Bandettini R; Oltolini C; Passera M; De Lorenzis G; Sargolzaei M; Crespan M; Cogliati M; Tortorano AM; Romanò L
    Mycoses; 2021 May; 64(5):528-536. PubMed ID: 33438319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azole preexposure affects the Aspergillus fumigatus population in patients.
    Alanio A; Cabaret O; Sitterlé E; Costa JM; Brisse S; Cordonnier C; Bretagne S
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4948-50. PubMed ID: 22710122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
    Bader O; Weig M; Reichard U; Lugert R; Kuhns M; Christner M; Held J; Peter S; Schumacher U; Buchheidt D; Tintelnot K; Groß U;
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3513-7. PubMed ID: 23669382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China.
    Chen Y; Lu Z; Zhao J; Zou Z; Gong Y; Qu F; Bao Z; Qiu G; Song M; Zhang Q; Liu L; Hu M; Han X; Tian S; Zhao J; Chen F; Zhang C; Sun Y; Verweij PE; Huang L; Han L
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5878-84. PubMed ID: 27431231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre.
    Abdolrasouli A; Scourfield A; Rhodes J; Shah A; Elborn JS; Fisher MC; Schelenz S; Armstrong-James D
    Int J Antimicrob Agents; 2018 Nov; 52(5):637-642. PubMed ID: 30103005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole resistance in canine and feline isolates of Aspergillus fumigatus.
    Talbot JJ; Kidd SE; Martin P; Beatty JA; Barrs VR
    Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():37-41. PubMed ID: 26387063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
    Rodriguez-Tudela JL; Alcazar-Fuoli L; Mellado E; Alastruey-Izquierdo A; Monzon A; Cuenca-Estrella M
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2468-72. PubMed ID: 18474574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.
    Gregson L; Goodwin J; Johnson A; McEntee L; Moore CB; Richardson M; Hope WW; Howard SJ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5778-80. PubMed ID: 24041890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Diversity of Azole-Resistant Aspergillus fumigatus in the United States.
    Etienne KA; Berkow EL; Gade L; Nunnally N; Lockhart SR; Beer K; Jordan IK; Rishishwar L; Litvintseva AP
    mBio; 2021 Aug; 12(4):e0180321. PubMed ID: 34372699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles.
    Nawrot U; Kurzyk E; Arendrup MC; Mroczynska M; Wlodarczyk K; Sulik-Tyszka B; Wróblewska M; Ussowicz M; Zdziarski P; Niewinska K; Brillowska-Dabrowska A
    Med Mycol; 2018 Jan; 56(1):121-124. PubMed ID: 28340159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
    Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
    J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Center Evaluation of an Agar-Based Screening for Azole Resistance in Aspergillus fumigatus by Using VIPcheck.
    Buil JB; van der Lee HAL; Rijs AJMM; Zoll J; Hovestadt JAMF; Melchers WJG; Verweij PE
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?
    Nabili M; Shokohi T; Moazeni M; Khodavaisy S; Aliyali M; Badiee P; Zarrinfar H; Hagen F; Badali H
    J Med Microbiol; 2016 Jun; 65(6):468-475. PubMed ID: 27008655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.